Physiologically-Based Pharmacokinetic Modeling Characterizes the CYP3A-Mediated Drug-Drug Interaction Between Fluconazole and Sildenafil in Infants

Physiologically-based pharmacokinetic (PBPK) modeling can potentially predict pediatric drug-drug interactions (DDIs) when clinical DDI data are limited. In infants for whom treatment of pulmonary hypertension and prevention or treatment of invasive candidiasis are indicated, sildenafil with flucona...

Descripción completa

Detalles Bibliográficos
Autores principales: Salerno, Sara N., Edginton, Andrea, Gerhart, Jacqueline G., Laughon, Matthew M., Ambalavanan, Namasivayam, Sokol, Gregory M., Hornik, Chi D., Stewart, Dan, Mills, Mary, Martz, Karen, Gonzalez, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8138939/
https://www.ncbi.nlm.nih.gov/pubmed/32691891
http://dx.doi.org/10.1002/cpt.1990

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8138939/
https://www.ncbi.nlm.nih.gov/pubmed/32691891
http://dx.doi.org/10.1002/cpt.1990

Ejemplares similares